Skip to main content
915 TLDR
Politics
1 read

Trump Considers Dismissal of FDA Chief Amid Rising Controversy

KVIACNN Newsource
Government building representing politics and policy news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

President Donald Trump has approved a plan to potentially remove FDA Commissioner Dr. Marty Makary due to increasing criticism regarding his management of the agency, particularly concerning drug approvals and access to the abortion pill mifepristone. Although no formal dismissal has occurred yet, pressure from anti-abortion activists and pharmaceutical industry officials has intensified, leading to discussions about Makary's job security. The FDA is currently without a permanent director for the CDC and a surgeon general, which adds to the instability within the health department as midterm elections approach. The situation highlights the ongoing tensions within the administration regarding health policies and their implications for abortion access nationwide.

Key Details: • Trump's decision on Makary's dismissal is pending, with no formal action taken yet. • A meeting with anti-abortion activists is scheduled for Friday evening. • Medication abortion now accounts for about two-thirds of all US abortions. • The Supreme Court may soon decide on a case affecting mail orders of abortion pills.

health trump abortion fda midterms

People & Organizations

Donald TrumpFDADr. Marty MakarySusan B. Anthony Pro-Life AmericaMarjorie DannenfelserDavid WilliamsTaxpayers Protection Alliance

Related Articles